AJNMMI Copyright © 2011-present, All rights reserved. Published by e-Century Publishing Corporation, Madison, WI 53711, USA
Forthcoming Titles
(PDFs in this page may not be proofed yet)


Ramasamy Paulmurugan, et al: Imaging estrogen receptor in tamoxifen resistant breast cancer: exploration of new modes of receptor regulation. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

David M Schuster, et al: Characterization of primary prostate carcinoma by anti-1-amino-2-[18F] -fluorocyclobutane-1-carboxylic acid (anti-3-[18F] FACBC) uptake. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Nandi A, Kuwabara H, et al: Integrated data analysis environment (IDAE) for neuroimaging studies with microPET. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

James M Mountz, et al: Imaging biomarker assessment of early therapy response for personalized management in cancer. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Zibo Li, et al: Hepatic stellate cells (HSC)-targeted imaging and therapy for liver fibrosis. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Xiankai Sun, et al: Peptoid-based PET imaging of VEGFR2 expression. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Georges El Fakhri, et al: Quantitative dynamic PET. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Lei Xing, et al: Investigations of dual modality X-ray and optical luminescent imaging. Am J Nucl Med Mol Imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Zhenghong Lee, et al: PET imaging of hepatocellular carcinoma. Am J Nucl Med Mol Imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

W. Barry Edwards, et al: Imaging reactive oxygen species in prostate tumor xenografts. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Zhaofei (Jeff) Liu, et al: Directly and indirectly 99mTc-labeled monoclonal antibody 3H11 for cancer detection. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Zhaofei (Jeff) Liu, et al: Peptide-based radiopharmaceuticals for tumor targeted radionuclide therapy. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

PD Habib Zaidi, et al: Molecular imaging technology in the era of molecular medicine. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Irina Velikyan, et al: Preparation and evaluation of a 68Ga-labelled RGD-containing octapeptide: bioditribution in Rhesus monkey. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Bradley T. Christian, et al: In vivo characteristics of a novel a4b2 nicotinic PET radioligand. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Onofre T. DeJesus, et al: Assessment of aromatic amino acid decarboxylase activity in vivo in health and disease. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Peeyush Bhargava, et al: SPECT/CT imaging acquisition, processing and display paramaters. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.

Xianzhong Zhang, et al: Chitosan based 99mTc agent for folate-receptor-mediated targeting. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Timothy R DeGrado, et al., Choline-PET and tumor aggressiveness phenotype. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Wawrzyniec L. Dobrucki, et al: Multimodal molecular imaging of angiogenesis in cardiovascular complications. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Edward E. Graves, et al: Molecular imaging of radiation response: Challenges and opportunities. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.

Chin-Tu Chen, et al: Integrative multi-modality molecular imaging: hybrid imaging devices. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Chin-Tu Chen, et al: Integrative multi-modality molecular imaging: probes. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Chin-Tu Chen, et al: Multi-modality molecular image co-registration, reconstruction, and analysis. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.

Kimberly Kelly, et al: Comparison of SPECT and PET imaging for plectin-1 imaging of pancreatic cancer. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Tracy R. McKnight, et al: Molecular imaging of p53-mediated therapeutic response in gliomas. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.

Feng Cao, et al: Molecular Imaging of stem cell in therapeutic angiogenesis. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Jinming Gao, et al: Theranostic nanomedicine for cancer imaging and therapy. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Fuyou Li, et al: lanthanide-based nanoparticles for multimodality bioimaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Edward J. Delikatny, et al: Imaging phospholipase activity in murine models of rheumatoid arthritis. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Hui Mao, Anthony W. Chan, et al: Molecular Imaging with genetically engineered MRI reporters. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.

Andrei Iagaru, et al: PET/CT in the Management of Sarcomas. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Jin Xie, et al: Composite nanoparticles for cancer imaging and therapy. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Scott Perlman, et al: Clinical Molecular Imaging with PET Agents Other than 18F-FDG. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Weibo Cai, et al: Non-invasive imaging of iPS Cells. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Frank Wuest, et al: 4-[18F]Fluoro-N-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide ([18F]-SA): A suitable click chemistry building block for 18F labeling of peptides, proteins and oligonucleotides. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Joseph M. Backer, et al: Imaging and targeting angiogenesis. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Kai Chen, et al: Application of NGR-containing peptides for tumor imaging and therapy. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Jason P. Holland, et al: Beyond molecular imaging: annotating oncogene activity with PET. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Vladimir Tolmachev, et al: Scaffold proteins, a new class of targeting agents for molecular imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Dongfeng Pan, et al: A novel near-infrared fluorescence imaging probe for in vivo neutrophil tracking. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Dongfeng Pan, et al: Synthesis and Evaluation of a Tumor-targeting SPECT/Fluorescence Dual-imaging agent: PC-1001. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Mian Alauddin, et al: Novel probes for PET imaging of cellular proliferation. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Zdravka O. Medarova, et al: Nanoparticles for Molecular Imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Guozheng Liu, et al: Islet cell imaging:  a hundred times more difficult than ever experienced. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Henning Boecker, et al: The endorphinergic system in exercise research. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Wellington Pham, et al: Preclinical evaluation of a novel nanobeacon for imaging colorectal cancer. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

H. Charles Manning, et al: Imaging TSPO expression in oncology. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Ran C, Anna Moore A. Cherenkov radiation for in vivo imaging and therapy. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Zhonglin Liu, et al: Imaging of inflammatory response in ischemic-reperfused myocardium. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Duane J Myklejord et al., Molecular imaging of Tie-2 expression.  Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Kusmirek JE et al., Molecular imaging of c-Met expression. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Witte KE et al., PET imaging of pancreatic Cancer. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Hall LT, PET imaging of brain tumor. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Sandip Biswal, et al: Imaging Pain and Nociception. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Jennifer Cochran, et al: Molecular imaging with disulfide-rich polypeptides. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Robin P. Choudhury, et al: Molecular imaging in acute ischemic syndromes. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Reinhard Meier, et al: Optical Imaging for Detection of Inflammation. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Tarik F. Massoud, et al: Molecular Neuroimaging: Current and Future developments. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Ming Zhao, et al: Whole-body imaging of irradiation-induced apoptosis using 99mTc-Duramycin. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.

Fabian Kiessling, et al: Nano- and microparticles for ultrasound-based diagnosis and therapy. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Ilan Ziv, et al: Clinical Molecular Imaging of Apoptosis: from bench to bedside. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Arutselvan Natarajan, et al: Development of immunoreagants for novel cancer biomarker dicovery. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.

Jean-Luc Vanderheyden, et al: Connecting the dots: Role of chemistry and translational imaging in the future of Molecular Imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Byeong-Cheol Ahn, et al: A false positive uptakes on radioiodine whole body scan. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Evan  D. Morris, et al: Imaging Neurotransmitter Dynamics with PET. A review of ntPET methods. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.

Yu-Shin Ding, et al: PET imaging of norepinephrine transporter: application to studies of cocaine dependence and ADHD. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Wengen Chen, et al: Molecular imaging of vulnerable atherosclerotic plaque (review). Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Omid Farokhzad,, et al: Nanotechnology in cancer therapy and imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Jan Grimm, et al: Cerenkov Imaging - a new imaging modality for molecular imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Ralph P. Mason, et al: Dynamic bioluminescent imaging: an effective tool to evaluate vascular disrupting agents. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Benjamin J. Hackel, et al: Design Parameters for Molecular Imaging Agents. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Katherine A. Vallis, et al: Auger electron therapy using radioimmunoconstructs, bispecific for EGFR and DNA damage signaling proteins. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Simon Ametamey, et al: Radiosynthesis and biological evaluation of a new mGluR5 PET radioligand. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Marina Emborg, et al: Molecular imaging of animal models of cardiac neurodegeneration. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Michael Hofman, et al: Scintillating Imaging with Gallium-68 PET/CT: new insights from old tracers. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Ming-Kai  Chen, et al: Optimizing imaging acquisition with minimized radiation exposure for F-18 FDG PET-CT. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Ming-Kai  Chen, et al: The utility of a pretherapy scan in determining I-131 radioablative dose for thyroid cancer. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Frank Roesch, et al: Long-term molecular imaging of 90Nb-labelled monoclonal antiboides. Am J Nucl Med Mol Imagin g2017;7(x):xx-xx.

Mohsen Beheshti, et al: Imaging of prostate cancer with PET/CT using radiolabeled choline derivatives. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Lily Yang, et al: Multimodality tumor imaging for effective treatment of drug resistant cancers. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Richard P. Baum, et al: Molecular imaging and radiopeptide therapy of neuroendocrine tumors. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.

Bart Cornelissen, et al: Auger electron therapy of cancer cells and tumor xenografts using 111In-labelled F3-peptide. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Stefano Fanti, et al: the clinical use of PET with 11C-Acetate. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Jiang He, et al: Pretargeting for cancer imaging and therapy. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Nanguang Chen, et al: Rotational probe for breast imaging with diffusive light. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Jeng-Jong Hwang, et al: Therapeutic evaluation of human breast carcinoma using enolase as a molecular target with molecular imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Mohsen Beheshti, et al: Imaging of prostate cancer with PET/CT using radiolabeled choline derivatives. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Thaddeus J. Wadas, et al: Prostate cancer imaging and PET. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Ed X. Wu, et al: Manganese-enhanced MRI of visual components and pathways. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

S. Sendhil Velan, et al: Multimodal imaging of brown fat in metabolic disease. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Henry K.F. Mak et al., Diffusion tensor imaging and MR spectroscopy at 3-tesla in neuropychiatric systemic lupus erythematoisus. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Henry K.F. Mak et al., Quantitative MR spectroscopy in aging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Bin Liu, et al: Conjugated Polymer Nanoparticles for Targeted Fluorescence Imaging of Cancer Cells. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Yan Zhang, et al: Imaging of proteases over-expressed in tumor microenvironment. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Wing-tak Wong, et al: Peptide-labeled AuNPs as a NIR/MR/Micro-CT contrast agent for targeted imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Eyal Mishani, et al: PET myocardial perfusion imaging agents- the new generation. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Ralf Schirrmacher, et al: Radioactively labeled proteins in nuclear imaging: A new generation of imaging agents. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Sean Carlin, et al: Sequential registered dynamic MRI and 18F-FMISO PET following VEGFR blockade. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

David RJ Owen, et al: Imaging the translocator protein. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Alexander K. Converse, et al: Regional cerebral blood flow response to amphetamine in rat measured by [17F]fluoromethane PET. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Jogesh Mukherjee, et al: Fallypride PET for Brain Dopamine Receptor Imaging- What have we learnt? Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Seo Y, et al: Translation multipinhole-multiaperture SPECT. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Hideo Saji, et al:  Radiolabelled probes for atherosclerotic plaque imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Jamal Zweit et al, Targeted Multi-Signal Nano-Probes: Implications for multi-modality molecular Imaging and nano-Therapy. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Gary L. Griffiths et al., The Imaging Probe Development Center at the National Institutes of Health: a core chemistry facility supplying molecular probes to diverse bioscientists since 2007. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Jun Toyohara, et al: Longitudinal small-animal PET imaging of 11C-4DST in turpentine-inducel inflamatiory tissue. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Shuanglong Liu, et al: Novel 18F-labeled aliphatic probe for melanoma imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Barbara Fischer, et al: PET/CT for radiotherapy planning or PET/MRI - current status and future perspectives. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Orit Jacobson, et al: Carbon-11 labeled benzimidazole inhibitor of TIE-2 and VEGFR-2 receptor tyrosine kinases as a molecular imaging agent for angiogenesis. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Sangeeta Ray, et al: Radiometals for imaging and therapy of prostate cancer. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Guo-Jun Zhang, et al: The functional roles of CXCR4 in triple-negative breast cancer using in vivo bioluminescence imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

James R. Mansfield, et al: Automated segmentation and quantitation of in-vivo fluorescence images using machine-learning. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Kuniaki Ogasawara, et al: Prediction of cerebral hyperperfusion following endarterectomy for unilateral cervical internal carotid artery stenosis using preoperative 123I-iomazenil SPECT imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Eric O. Aboagye, et al: Imaging with choline radiotracers. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Jae Sung Lee, Sujin Kim, Dong Soo Lee: Multiple linear analysis for reversible and irreversible radiotracers. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Orhan K. Oz, et al: Molecular and functional imaging of bone. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Ronald Boellaard, et al: Quantification and simplified measure in PET. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Imene Zerizer, et al: Role of FDG PET/CT in radiotherapy of gynaecological malignancies: Where are we now? Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Susan L. Deutscher, et al: In vivo selection of rapidly excreted phage-displayed peptides. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Philip W. Miller, et al: Recent developments in microfluidic methods for high speed radiolabelling in PET. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Susanne Keiding, et al: Functional molecular imaging of the liver. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Yumin Zhang, et al: Imaging with radiolabeled antibodies for the development of antibody-based therapeutics. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Yongjun Yan, et al: Molecular imaging probes targeting cancer vasculatur. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Zheng-Rong Lu, et al: Synthesis and evaluation of a targeted contrast agent for MR cancer molecular imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Felix M. Mottaghy, et al: Molecular imaging of therapy response with 18F-FLT-PET following cyclophosphamide and mTOR inhibition. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Thomas WD, Chuanbin Mao: Phage display enabled molecular imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Sangyong Jon, et al: High-affinity peptide based neclear imaging of cancers. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Andreas H. Jacobs, et al: imaging shRNA interference in gliomas. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Michael L. Goris, et al: Observation of global decreased brain FDG uptake, unrelated to primary neurological disease. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Young-tae Chang, et al: Novel multimodal nanoparticle sensors. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Farouc Jaffer, et al: Intravascular molecular imaging: progress towards the cardiac catheterization laboratory. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Rong Zhou, et al: Using imaging techniques to evaluate the survival and function of novel cardiomyocyte progenitor cells. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Stephen H Thorne, et al: Imaging of Biological Cancer Therapies. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Ornella E. Rimoldi, et al: Non-invasive evaluation of ischemic heart disease in women. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Albert  J.  Sinusas, et al: Nuclear imaging in peripheral arterial disease. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Anthony F. Shields, et al: FLT PET imaging, an update. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Michael Sørensen, et al: Molecular imaging of regional metabolic function of the liver. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Gang Huang, et al: Diagnostic value of (11)C-choline positron emission tomography in patients with PSA relapse after radical treatment of prostate cancer. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Henry Engler, et al: Imaging astrocytosis with PET in Creutzfeldt-Jakob disease: Case report with histopathological findings. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Keon Wook Kang, et al: In vivo nano-molecular imaging of cancer. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Luca Giovanella, et al: Role of preoperative 18FDG-PET/CT in patients with thyroid nodules. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Jae Sung Lee, Sujin Kim, Dong Soo Lee: Multiple linear analysis for reversible and irreversible radiotracers. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Luigi Mansi, et al: The role of radiopeptides in Nuclear Medicine. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Xiao-Feng Li, et al: Hypoxia microenviroment dependent 18F-FDG uptake in macroscopic and microscopic tumors. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Joseph A. O'Donoghue, et al: Clinical studies with the tumor hypoxia PET tracer 124I-IAZGP. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

François Bénard, et al: Overexpression of peptide receptors as targets for PET or SPECT radiopharmaceuticals: a breast cancer tissue microarray study. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Mikako Ogawa, et al: Molecular imaging probes for atherosclerosis imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Mathieu Hatt, et al: Potential impact of improved functional volume delineation algorithms in clinical practice. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Soonhag Kim, et al: In vivo imaging of microRNA124a-independent neuronal differentiation of human G2 neural stem cells. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

David M Schuster, et al: Synthetic amino acid imaging of primary prostate carcinoma: A pilot study. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.

Masahiro Fujita, et al: PET imaging of intracellular signal transduction systems. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Tapan K. Nayak, et al: Molecular imaging of EGFR. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Jason L. Dearling, et al: Use of PET and DW-MRI in the early detection of the response of neuroblastoma tumors to chemotherapy. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Roger R Fulton, et al: Evaluation of a patient motion correction technique for paediatric PET/CT imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Ryogo Minamimoto, et al: 99mTc-aprotinin for imaging of amyloidosis. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Christopher J. Endres, et al: The role of parameter coupling in quantitative PET. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Hans-Jürgen Biersack, et al: Lu-177 DOTATE therapy in NET. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

John O Prior, et al: Peritoneal carcinomatosis due to ovarian cancer: Comparison between MDCT, MRI and F-18-FDG PET/CT). Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Paolo Ciana, et al: Imaging estrogen receptor activity during neoplastic transformation of the mouse breast. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Elba Cristina Etchebehere, et al: THE role of PET/CT in radioablation. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Yi-Hwa  Liu, et al: New methods of image quantification for hybrid cardiac imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Ludwig G. Strauss, et al: Parametric imaging with dPET-CT in oncology. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Yun Zhou, et al: Recent advances in quantitative dynamic PET. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Lars Stelter, et al: Evaluation of Arginine deiminase therapy in malignant melanoma using molecular imaging strategies. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Jae Min Jeong, et al: F-18 labeled radipharmaceuticals. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Mingfeng Bai, et al: In vivo type 2 cannabinoid receptor targeted near infrared fluorescence imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

René A Tio, at al: Myocardial perfusion reserve: is it worth measuring? Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Hancheng Cai, et al: PET probes for reporter gene HSV1-tk imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Steve Y Cho, et al: FDG PET imaging of treatment response and prognosis in pediatric Hodgkin Lymphoma. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Ming-Rong Zhang, et al: Positron Emission Tomography Imaging of Inflammation in Peripheral Organs with Translocator Protein (18KDa) Radioligand. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Yongjian Liu, et al: Radionuclide-Based Molecular Imaging for Pulmonary Applications. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Jonathan F Lovell, et al: Folate-receptor targeting for fluorescence-switching nanoparticles. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Samer Ezziddin, et al: Bone metastases in GEP NET: Response and long-term outcome after PRRT from a follow-up analysis. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Ciprian Catana, et al: MR-assisted PET motion correction improves PET data quantification in simultaneous PET/MR brain imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Chenjie Xu, et al: Stem cell tracking with smart nanoparticles. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Paco E. Bravo, et al: Clinical significance of delayed enhancement on cardiac magnetic resonance confined to the right ventricular junctional segments in hypertrophic cardiomyopathy. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Tan To Cheung, et al: The role of 11C-Acetate and 18F-FDG PET/CT on the management of hepatocellular carcinoma. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Dexing Zeng, et al: Click chemistry and applications in the preparation of PET agents. Am J Nucl Med Mol Imaging2017;7(x):xx-xx.

Tan To Cheung, et al: The prognostic value of 11C-Acetate and 18F-FDG PET/CT on patient with hepatocelluar carcinoma treated by hepatectomy. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Gang Liu, et al: Functional magnetic nanoparticles for cardiovascular molecular imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Gianmario Sambuceti, et al: Bone marrow imaging in blood diseases. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

David L. Morse, et al: Targeting the cell-surface for cancer imaging”  or alternatively “Cell surface marker discovery for development of cancer targeted agents. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Rebecca A Dumont, et al: Novel preclinical applications for PET/MR. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Alan Jackson, et al: Molecular imaging of modifications of the blood/brain barrier in cerebral tumours. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Michael Lin, et al: Should FDG PET-CT be used routinely in staging colorectal cancers? Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Pablo R. Ros, et al: PET/MR in a clinical environment in the US: lessons learned. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Chandrasekhar Bal, et al: Role of  68Ga-Bisphsphonates in Skeletal Scintigraphy. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Simona Ben-Haim, et al: The correlation between baseline folate receptor expression measured by 99mTc-etarfolatide (99mTc-EC20) scans and response to treatment with Vintafolide in patients with advanced cancer. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Silvia Morbelli, et al: Cognitive reserve: implications for brain 18F-FDG and amyloid PET imaging. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.

Andrew C. Larson, et al: Nuclear Imaging Methods for Localization of Y-90 Microspheres Following Radioembolization. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Anne Roivainen, et al: 15O-Water and 68Ga-DOTA PET imaging for assessment of blood flow and vascular permeability in a rat model of inflammation – comparison with ultrasound imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Michael R. Lewis, et al: Copper-64-Labeled PNA-Peptide Conjugates Selectively Localize in BCL2-Positive Tumors in Mouse Models of B-cell Lymphoma/Leukemia. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Matthias Eder, et al: Fluorescein conjugates as tools to follow the intracellular distribution of the PET tracer Glu-urea-Lys-HBED-CC. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Andrew J Saykin, st al: TSPO PET as a biomarker for brain immune status. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Stefan Reuter, et al: 18F-fluoride positron emission tomography-based assessment of cisplatin nephrotoxicity in mice. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Olof Eriksson, et al:  Imaging of the endocrine pancreas: retrospective evaluation of clinically available neuroendocrine Positron Emission Tomography markers. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Olaf Prante, et al: Synthesis and in vivo Evaluation of an 18F-labeled glycoconjugate of PD156707 for imaging ET(A) receptor expression in thyroid carcinoma by positron emission tomography. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Michelle L James, et al: Positron Emission Tomography Imaging of Alzheimer's Disease Mouse Models. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Robert Hobbs, et al: Radioimmunotherapy of orbital lymphoma: 3D-RD dosimetry for eye, lens, optical nerve and tumor. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Guillem Pratx, et al: Cell microscopy with radioactive dyes. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Chongzhao Ran, et al: Spectral unmixing and its application in Molecular imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Adriana Alexandre S Tavares, et al: Lysophospholipid receptors: novel targets for brain imaging. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.

Daniel LJ Thorek, et al: Functional imaging of prostate cancer in mouse models. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Stavroula Sofou, et al: Evaluation of the therapeutic potential of vasculature-targeting liposomes loaded with alpha-particle emitters. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Orazio Schillaci, et al: The role of 18FDG positron emission tomography in the follow-up of  liver tumors treated with 90Yttrium radioembolization. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Richard Southworth, et al: Can we agree upon a unified approach for preclinical FDG PET imaging?  Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Philipp Heusch, et al: PET/MRI: an overview of current evidence in oncology. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Jens Siveke, et al: Imaging modalities for early tumor response evaluation. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Mike M. Sathekge, et al: Molecular Imaging of Tuberculosis. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.

Jingyi Chen, et al: Plasmonic nanoparticles for molecular imaging. Am J Nucl Med Mol Imaging 2017;7(x):xx-xx.






(The journal is now accepting manuscript submissions. Please go to Information for Authors to prepare your manuscript for
submission to American Journal of Nuclear Medicine and Molecular Imaging.)